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An extra-pulmonary tuberculosis (EPTB) infection rate of 30% in Saudi Arabia remains
above the global rate. A variable rate of infection in each province has been reported and
the involvement of most organs has been cited. Nationwide collective data on the current
trends of infection are scarce and the factors behind the increased rate of EPTB are perplex-
ing. This review endeavors to shed light into the epidemiology of EPTB, various types of
infections sites, geographical differences in the infection rate, known risk factors, and
challenges in the diagnosis and management of EPTB in Saudi Arabia.
 2015 Asian African Society for Mycobacteriology. Production and hosting by Elsevier Ltd.
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tuberculosis (TB) remains an enormous public health problem
[1]. A decreasing or stable trend of new TB cases was observed
from developed or industrialized nations. However, some
developing countries show an increasing trend, whereas
many others exhibit a very slow decline in incidence [1]. TB
is primarily a disease of the lungs (pulmonary tuberculosis
[PTB]), but can affect almost any organ in the body and the
occurrence at sites other than the lung is defined as
extra-pulmonary tuberculosis (EPTB). Despite the fact that
EPTB is a serious clinical problem because of the diagnostic
challenges encountered and the propensity to cause high
morbidity and mortality, it receives less interest mainly due
to low infectious potential [2,3]. The deadly synergisms
between TB and human immunodeficiency virus (HIV) with
the emergence of drug resistance have complicated the
control of TB globally.
Extra-pulmonary involvement of mycobacteria can mostly
happen through the lymphatic or hematogenous dissemina-
tion to any part of the body. In addition, the bacteria can stay
dormant for a very long time. Due to higher efficacy in
infecting any organ, the mycobacterium has a wide variety
of clinical manifestations. Additionally, EPTB poses certain
challenges in its diagnosis and management, even in
resource-rich countries. The diagnosis is always cumbersome
owing to the wide spectrum of clinical presentations, limited
specificity of manifestations, and difficulties in obtaining
specimens for diagnosis [4]. When considering the diagnostic
difficulties of EPTB, the real magnitude of the problem at the
community level may be underestimated, even with the
current management system in most countries, including
Saudi Arabia. To draw attention towards the magnitude of
EPTB infections, in this review we attempted to show the
current understanding of the epidemiology of EPTB, diversity
in its clinical presentations, and the future research prospects
required in Saudi Arabia.
Global trend on epidemiology and clinical pattern
of EPTB
EPTB has been reported in almost all global regions, particu-
larly in developed countries [1,4,5]. The World Health
Organization data shows 0.8 million EPTB cases among the
6.1 million of new TB cases reported in 2013 [1]. The HIV
epidemic, rising numbers of immigrants from developing
countries to developed countries, and a fair amount of
immune disorders are assumed to be responsible for this rise
in TB cases in many countries [1–3,6,7]. A 10-year surveillance
data from the European Union (EU) showed an increasing
trend of EPTB in the member states [8]. A 13 year data fromthe United States also showed an increasing proportion of
EPTB compared with the decreasing trend of PTB [9].
Trends of clinical patterns of EPTB in most global regions
were highly diverse in presentation. In the USA, a nationwide
report shows lymphatic TB (40.4%) as the most prominent
followed by pleural TB (19.8%), bone and joints TB (11.3%),
genitourinary (6.5%), tuberculous meningitis (5.4%), peritoneal
(4.9%), and 11.8% of other sites [9]. However, in the EU, the
trend was different as it showed a higher predominance of
pleural TB (36.7%), followed by lymphatic TB (30.5%),
genitourinary (6.9%), bone and joints (5.1%), central nervous
system (4.4%), gastrointestinal (2.7%), and other sites (9.4%)
[8]. Recent data from Brazil also showed a similar trend to
the EU, with the dominance of pleural TB (42%) followed by
lymphatic TB (21%), meninges (6%), bone (5%), genitourinary
(3%), miliary (8%), and others (15%) [10]. Nationwide data or
large scale data were scarce from the major TB endemic
regions of Africa and Asia.
Epidemiology of EPTB in Saudi Arabia
Annual case rates of EPTB have been recorded in Saudi Arabia
since 1989. A considerable drop in the rate of incidence was
reported in the initial period. However a gradual increase
was evident since 1994 [11]. In 1991, the proportion of EPTB
in the country was 11.7% of the total reported TB cases, fol-
lowed by a sharp increase to 28.2% in 1997 [12,13]. However,
a recent national TB notification registry data showed a con-
sistent level of EPTB cases in the country – around 30% of total
reported TB cases annually [14,15]. Fig. 1 explains the inci-
dence rate of EPTB reported during 2005–2012. Interestingly,
recent trends show a slight decrease in the rate of EPTB in
connection with the decreasing trend of total notified TB
cases in the country. The incidence rate ranges from 3.5–
5 cases/105 population in recent years when compared with
the total TB incidence of 17–21 cases/105 population in the
same period [14,15]. Nonetheless, a variation of EPTB propor-
tions was reported from several institutions, ranging from
15% to 63%. However, these data are based on a single institu-
tion and thus a nationwide picture could not be possibly
drawn. A recent nationwide study conducted only with cul-
ture positive cases reported 20% EPTB among the 1904
patients examined [16–20].
Until now there were only two nationwide studies that
looked deep into the clinical features and epidemiology of
EPTB in the country [21,22]. Memish et al. [21] reported on
the incidence and risk factors of EPTB on nationwide data col-
lected during 2010–2011 from the national disease notification
system. The data covered all the provinces of the country
through the current TB notification system. The data showed
Fig. 2 – This figure shows the relative proportions of extra-pulmonary tuberculosis in male and female patients in Saudi
Arabia along with the relative proportions against pulmonary TB. The data have been abstracted from the Ministry of Health
Annual statistics reports for the period 2006–2011. EPTB = extra-pulmonary tuberculosis; PTB = pulmonary tuberculosis.
Fig. 1 – The figure shows the incidence rate of extra-pulmonary tuberculosis in Saudi Arabia during 2005–2012, data
abstracted from the annual statistics reports of the Ministry of Health of Saudi Arabia.
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2011. In particular, Saudi nationals are more prone to EPTB
than non-Saudis, and females are mostly getting EPTB than
PTB. Interestingly, house wives and household workerssharing the same environment were found with higher pro-
portions of EPTB [21]. Recently, another nationwide data on
381 culture positive EPTB cases collected during 2009–2010
showed almost similar findings of the previous study [21],
Fig. 3 – The figure shows the relative proportions of extra-pulmonary tuberculosis in five major geographical regions of the
Kingdom. These values are against the pulmonary tuberculosis percentage abstracted from the annual statistics books of the
Ministry of Health of Saudi Arabia for the period of 2006–2012.
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factors.
Gender associated incidence of PTB and EPTB in
Saudi Arabia
Data published by the Ministry of Health of Saudi Arabia on
the national incidence of tuberculosis during 2006–2011
showed a higher relative incidence of EPTB among
female patients. Another recent study also reported the
predominance of EPTB among females compared with males,
particularly among household workers and their close
contacts [21]. Fig. 2 depicts the proportions of EPTB among
male and female patients during the period of 2006–2011
and the relative proportions of EPTB against PTB. Saudi
Arabia also shows the same trend as the rest of the world,
that female gender is a predisposing risk factor for the
development of EPTB as opposed to PTB [2–5,9,23].
Geographical difference of EPTB prevalence in
Saudi Arabia
The geographical differences in relative proportions of EPTB
with PTB were clearly visible in major provinces of Saudi
Arabia. Annual TB incidence notification published by the
Ministry of Health has been adapted to make an analysis for
a period of 7 years (2006–2012). The results are abstracted in
Fig. 3. The major finding showed that central provinces of
the country consistently reported a relative proportion of
34–41% EPTB in the past 7 years. In 2006, Northern provinces
reported the highest proportion of EPTB as 42.6%. Later, the
trend showed a decline in EPTB incidence in the North similar
to the Eastern provinces. Surprisingly, most populatedprovinces of the West and South showed comparatively lower
proportions of EPTB (Fig. 3). Another recent study also showed
a similar trend of EPTB proportions in different provinces of
the country [21].
Clinical patterns of EPTB in Saudi Arabia
Clinical patterns of EPTB in the country in most of the recent
studies showed huge diversity in manifestations. Most com-
mon sites of infection reported in the country were lymph
nodes, bones, abdomen, nervous system, and pleura followed
by all other rare sites including miliary TB. Fig. 4 depicts
the results of a literature review which analyzed the
extra-pulmonary sites of infection abstracted from various
published studies during 1990–2013 in Saudi Arabia.
A couple of studies recently showed, for the first time, the
data on clinical features of EPTB in the country with a domi-
nation of lymphatic TB. Data by Memish et al. [21] showed the
second most common site of infection is bone, followed by
central nervous system and gastrointestinal system, while
Al-Hajoj et al. [22] reported gastrointestinal, central nervous
system, followed by bone, respectively, as the most infected
sites (Fig. 5). However, this difference can be mainly due to
the sample collection strategy, as Al-Hajoj et al. [22] reported
only on confirmed culture positive cases while other data was
from the national TB reporting registry. Furthermore, the vari-
ations may point out the difficulties faced in diagnosing and
proper sampling for culturing of the isolates.
Lymphatic TB
Intrathoracic and extra thoracic lymph nodes are the most
affected site of infection by Mycobacterium tuberculosis among
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common, but inguinal, axillary, mesenteric, submandibular,
and mediastinal involvement have been described in differ-
ent studies [24–26]. Lymphadenitis is common in all regions
of the country and prevails with an average of 40% of the
reported EPTB cases [20,27,28]. In Saudi Arabia, lymphatic
TB is a disease of young adults, as the majority of patients
were younger than 35 years. Furthermore, a higher prepon-
derance of female gender was also noticed in many studies
reported with lymphatic TB in the country [28]. This finding
is in contrast with a trend in the Western world, where
lymphatic TB is more common among the elderly.
Preponderance of females with lymphatic TB may have a
direct impact from the population structure of immigrants,
particularly household workers from the TB endemic regions.
They are sequestrated in the close environment of houses
with constant exposure to family members. Varghese et al.,
recently proposed the chances of effective transmission of
TB among households through the relatively close activity
between house maids and family members [29,30].
Interestingly, after the introduction of the new vaccine strain
(Danish SSI 1331) for routine administration, a slight elevation
in the rate of lymphatic TB among children younger than
1 year was serially reported [31,32].
Central nervous system
Brain tuberculoma, meningitis, intracranial tuberculoma, and
spine TB are the most common infections reported in the
country affecting the central nervous system [33–37].
However, other rare forms of TB to sites like the craniocervicalFig. 4 – This illustration is created from data abstracted from an
using the terms ‘‘extra-pulmonary tuberculosis in Saudi Arabia
in Saudi Arabia’’, and ‘‘Mycobacterium tuberculosis in Saudi Arabjunction and lumbar root, along with serious concern on ver-
tebral and paravertebral sites also were reported [16,20,38,39].
A recent study on a nationwide data collection reported an
overall proportion of 7.1% central nervous system TB among
the total EPTB cases reported [21]. In addition, another nation-
wide study on culture positive cases showed the predomi-
nance of 11.8% of central nervous system TB during 2009–
2010 [22]. Central nervous system TB is more confined to
the adults in the country. Interestingly, tuberculosis meningi-
tis and other form of central nervous systems TB are reported
less among children [39,40].Gastrointestinal TB
Abdominal or gastrointestinal TB is one of the common man-
ifestations of EPTB in Saudi Arabia [16,33,41]. The national
average of reported cases of gastrointestinal TB during
2010–2011 was 5.4%. Al-Hajoj et al. [22] reported a proportion
of 17.3% of culture confirmed gastrointestinal TB cases from a
nationwide sample collection. Involvement of various sites of
the abdomen, predominantly the peritoneum, liver, and small
intestine were reported in the country [33,42]. Colon, spleen,
pancreas, ileocecum, esophagus, duodenum, umbilical area,
and abdominal wall were also reported with TB in several
studies [41–45]. TB peritonitis (results mostly from the reacti-
vation of latent foci in the peritoneum) is the most common
clinical manifestation reported among patients with HIV
infection or cirrhosis and in those undergoing continuous
ambulatory peritoneal dialysis from different provinces of
the kingdom [33,42,46].online literature review (PubMed, Google Scholar) conducted
’’, ‘‘tuberculosis in Saudi Arabia’’, ‘‘tuberculosis case reports
ia’’.
Fig. 5 – Series-1: Memish et al. [21]; Series-2: Al-Hajoj et al. [22].
266 I n t e r n a t i o n a l J o u r n a l o f M y c o b a c t e r i o l o g y 4 ( 2 0 1 5 ) 2 6 1 –2 6 9Bone and joints
Bone TB predominates as the second most common site
of EPTB in the country during 2010–2011 with an overall
proportion of 8.2% [21]. Arthritis and spondylitis caused
by M. tuberculosis is generally established as a clinical
manifestation [47–49]. However, TB of the sternum, ribs, knee
joint, zygomatic bone, talus, and cuboid have also been
reported as rare incidences recently [50–52].
Pleural TB
In developed countries, pleural TB is the second most
common form of EPTB after lymphatic TB [4,9,53]. Countries
like Brazil and Poland showed pleural TB as the first
predominated form of EPTB ahead of lymphatic TB [10,23].
However, in Saudi Arabia, a recent study analyzed with
culture positive EPTB cases placed pleural TB in the fourth
position. Pleural effusion is a well know clinical manifesta-
tion of TB. The largest series of pleural TB was reported from
the Eastern province of the country during 1994. The study
showed 35.2% of the 253 patients reported with pleural
effusion had TB. Of the total 89 cases, 82% were men, 34.3%
Saudi nationals, and 92% of them were positive to Mantoux
testing [54]. A recent study recorded pleural TB among HIV
positive patients [33].
Other rare sites
Any sites other than lymphatic, gastrointestinal, central ner-
vous system, osteoarticular, and pleural were classified as
other rare sites. A recent study (Memish et al.) showed 31%
of the total notified EPTB cases during 2010–2011 belonged
to other rare sites, which is relatively very high comparedwith other global regions [2,4,9,21,23,53]. In a literature review
(1990–2013), it has been noticed that involvement of rare sites
in EPTB is common in Saudi Arabia. Genital TB was a common
EPTB manifestation in the 1980s and 1990s in the country.
Several previous studies reported the existence of a large level
of female genital TB infections particularly among the local
population [16,20,45,55]. In addition, TB of the testis (particu-
larly epididymo-orchitis), prostrate glands, urinary tract, and
a rare involvement of penis also were reported [42,56–59].
Pericardial TB is another rare manifestation of EPTB reported
in Saudi Arabia. Raafa and Mosieri [60] reported in a study
conducted during 1981–1989 that 83% of the patients who
underwent pericadectomy in an institutional heart center
were observed with TB constrictive pericardial disease.
However, reports were limited on pericardial TB recently
except a few which reported among patients who underwent
peritoneal dialysis or were reactive to HIV antigens [33,42,61].
Ocular TB (uveitis, choroidal granuloma), cutaneous TBs,
and bone marrow TB were reported previously in the country
by several institutions [16,20,57,62–64]. Interestingly, a case of
congenital TB was reported as cutaneous disease in the
Central province [65]. Other sparingly reported sites of EPTB
infections are thyroid glands and kidney [20,61,66,67]. In addi-
tion, some other rare sites of TB infection have also been
reported, such as the parotid gland, tongue, finger, toe, and
nasolacrimal mucosa [68–70]. Miliary and disseminated TB
were reported in most of the major provinces of Saudi
Arabia [24,33,71].
Established risk factors for EPTB in Saudi Arabia
Very few studies analyzed in detail the risk factors of EPTB in
Saudi Arabia. Recently, Memish et al. [21] on an independent
analysis reported the major risk factors for EPTB. The report
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origin, and semi-skilled jobs as independent significant risk
factors. Several previous clinical studies reported different
conditions as predisposing factors among EPTB patients.
The most reported underlying conditions were peritoneal
dialysis and hemodialysis, which were reported with almost
all type of EPTB cases [42,61,72]. The other risk factors which
were reported in different studies are HIV, breast cancer, dia-
betes, chronic liver and renal disease, leukemia, neo-
plasia/immunosuppression, thrombocytopenic purpura,
transplantations, and immunosuppressive therapy and
chronic use of steroids [20,33,46,67,72,73]. However, these fac-
tors were never analyzed independently to prove their real
significance. The role of primary immunodeficiencies (PIDs)
to make the host susceptible to TB was clearly observed in
different studies [74–76]. Saudi Arabia is reported with the
highest incidence (up to 67%) of consanguinity and related
immune disorders in the world, which may have serious
implications that need to be explored [77,78]. In addition,
Saudi Arabia reports with an increased rate of several PIDs
such as chronic granulomatous disease (5.2 cases/105 live
births), severe combined immunodeficiency syndrome
(19 cases/105 live births) which is considered as the highest
in the world [79,80]. The consequences of PIDs on various
infectious diseases including TB development have been
reported previously from different regions including Saudi
Arabia [81,82]. Thus, we insist on the fact that the large
existence of PIDs in the country may have a direct influence
on the large scale consistent reporting of EPTB predominance
among the Saudi Arabian population. Thus, exploring the real
risk factors of EPTB among Saudi and non-Saudi populations
may be beneficial in an improved clinical management of
EPTB in the country.
Challenges in EPTB diagnosis
Virtually any organ can be infected by EPTB, thus it has a
variety of clinical manifestations that cause delays and
difficulties in getting a timely diagnosis. Like any other devel-
oping country, Saudi Arabia also faces certain difficulties in
the clinical management of EPTB. Advanced clinical infras-
tructure is under development in many parts of the country.
Furthermore, currently major cities only provide the ultimate
supports for the diagnosis of crucial and rare cases of EPTB
which occasionally limit the access of patients from remote
areas. The same as in most of the global region, the differen-
tial diagnosis of EPTB is challenging for physicians who are
not well trained or experienced in TB management. In addi-
tion, the implementation of modern diagnostic technologies
to all the possible centers is still under progress. Generally,
the established challenges involve the difficulty in obtaining
an adequate sample. Aliqouting the sample for various proce-
dures compromises the uniform distribution of microorgan-
isms, pauci-bacillary nature of the clinical samples,
presence of inhibitors that undermine the performance of
molecular techniques, and the lack of a universal sample pro-
cessing technique for extra-pulmonary samples [83].Conclusion
Saudi Arabia faces a considerable challenge from EPTB. The
consistent incidence of EPTB in the country is higher than
most global regions. Clinically, almost all organs were
reported with TB in the country. However, the confounding
factors of EPTB including the immuosuppressive conditions
related to genetical disorders were never independently ana-
lyzed. Therefore, a nationwide study emphasizing the various
risk factors of EPTB is warranted.Conflicts of interest
No conflicts of interest to declare.
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